Home 
Bratislava Medical Journal 2019 Bratislava Medical Journal Vol.120, No.2, p.131–138, 2019
Bratislava Medical Journal 2019 Bratislava Medical Journal Vol.120, No.2, p.131–138, 2019
Journal info
|
||||
Select Journal
Journals
Bratislava Medical Journal 2024 Ahead of print 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 Endocrine Regulations General Physiology and Biophysics Neoplasma Acta Virologica Studia Psychologica Cardiology Letters Psychológia a patopsych. dieťaťa Kovove Materialy-Metallic Materials Slovenská hudbaWebshop Cart
Your Cart is currently empty.
Info: Your browser does not accept cookies. To put products into your cart and purchase them you need to enable cookies.
Bratislava Medical Journal Vol.120, No.2, p.131–138, 2019 |
||
| Title: The role of selenium in bevacizumab induced cardiotoxicity | ||
| Author: C. R. Oncel, I. S. Ovey | ||
| Abstract: OBJECTIVE: We investigated the role of selenium in bevacizumab induced cardiotoxicity and involvement of transient receptor potential vanilloid 1 (TRPV1) channels in cardiomyocytes. MATERIALS AND METHODS: All cells (Human cardiomyocyte cell line) were cultured at 37 °C. We divided the cells into seven groups as control, bevacizumab, bevacizumab + capsazepin, bevacizumab + selenium, bevacizumab + selenium + capsazepin, selenium and selenium + capsazepin groups. Cells in the groups were stimulated with capsaicin and inhibited with capsazepin in related experiments for activation and inactivation of TRPV1 channels, respectively. RESULTS: Cytosolic calcium, apoptosis and intracellular ROS production levels were lower in bevacizumab + selenium group than in the bevacizumab group of cardiomyocytes (p ˂ 0.001). Also, values were markedly lower in the bevacizumab + selenium + capsazepine group when compared to the bevacizumab + selenium group (p ˂ 0.001). CONCLUSION: We found that cytosolic calcium, apoptosis, intracellular ROS production levels were increased in bevacizumab induced cardiotoxicity and selenium treatment could have beneficial effects on these parameters (Fig. 5, Ref. 51). |
||
| Keywords: apoptosis, bevacizumab, cardiomyocyte, transient receptor potential vanilloid 1, selenium | ||
| Published online: 17-Feb-2019 | ||
| Year: 2019, Volume: 120, Issue: 2 | Page From: 131, Page To: 138 | |
| doi:10.4149/BLL_2019_021 |
||
|
|
 download file |
|